142 related articles for article (PubMed ID: 36781089)
21. Brief Opioid Exposure Paradoxically Augments Primary Afferent Input to Spinal Excitatory Neurons via α2δ-1-Dependent Presynaptic NMDA Receptors.
Chen SR; Chen H; Jin D; Pan HL
J Neurosci; 2022 Dec; 42(50):9315-9329. PubMed ID: 36379705
[TBL] [Abstract][Full Text] [Related]
22. Positive interaction between GPER and β-alanine in the dorsal root ganglion uncovers potential mechanisms: mediating continuous neuronal sensitization and neuroinflammation responses in neuropathic pain.
Xu Z; Xie W; Feng Y; Wang Y; Li X; Liu J; Xiong Y; He Y; Chen L; Liu G; Wu Q
J Neuroinflammation; 2022 Jun; 19(1):164. PubMed ID: 35729568
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor 13 stabilizes microtubules to promote Na
Wang Q; Yang J; Wang H; Shan B; Yin C; Yu H; Zhang X; Dong Z; Yu Y; Zhao R; Liu B; Zhang H; Wang C
J Adv Res; 2021 Jul; 31():97-111. PubMed ID: 34194835
[TBL] [Abstract][Full Text] [Related]
24. Allium macrostemon Bunge. exerts analgesic activity by inhibiting NaV1.7 channel.
Yang X; Dai Y; Ji Z; Zhang X; Fu W; Han C; Xu Y
J Ethnopharmacol; 2021 Dec; 281():114495. PubMed ID: 34364968
[TBL] [Abstract][Full Text] [Related]
25. δ-Opioid receptors in primary sensory neurons tonically restrain nociceptive input in chronic pain but do not enhance morphine analgesic tolerance.
Jin D; Chen H; Huang Y; Chen SR; Pan HL
Neuropharmacology; 2022 Oct; 217():109202. PubMed ID: 35917874
[TBL] [Abstract][Full Text] [Related]
26. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
27. Tannic acid modulates excitability of sensory neurons and nociceptive behavior and the Ionic mechanism.
Zhang X; Zhang H; Zhou N; Xu J; Si M; Jia Z; Du X; Zhang H
Eur J Pharmacol; 2015 Oct; 764():633-642. PubMed ID: 26134502
[TBL] [Abstract][Full Text] [Related]
28. RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and
Zhang J; Chen SR; Chen H; Pan HL
J Biol Chem; 2018 Dec; 293(49):19078-19091. PubMed ID: 30327427
[TBL] [Abstract][Full Text] [Related]
29. Potent Ca
Kamau PM; Li H; Yao Z; Han Y; Luo A; Zhang H; Boonyarat C; Yenjai C; Mwangi J; Zeng L; Yang S; Lai R; Luo L
Biomed Pharmacother; 2022 Sep; 153():113310. PubMed ID: 35728351
[TBL] [Abstract][Full Text] [Related]
30. Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1.
Schachtele SJ; Hu S; Sheng WS; Mutnal MB; Lokensgard JR
Glia; 2014 Oct; 62(10):1582-94. PubMed ID: 24890099
[TBL] [Abstract][Full Text] [Related]
31. Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons.
Qiu F; Qiu CY; Cai H; Liu TT; Qu ZW; Yang Z; Li JD; Zhou QY; Hu WP
Br J Pharmacol; 2014 Jun; 171(12):3065-76. PubMed ID: 24641084
[TBL] [Abstract][Full Text] [Related]
32. Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
Chen R; Coppes OJM; Urman RD
Pain Physician; 2021 Mar; 24(2):153-163. PubMed ID: 33740349
[TBL] [Abstract][Full Text] [Related]
33. Profound analgesia is associated with a truncated peptide resulting from tissue specific alternative splicing of DRG CA8-204 regulated by an exon-level cis-eQTL.
Upadhyay U; Zhuang GZ; Diatchenko L; Parisien M; Kang Y; Sarantopoulos KD; Martin ER; Smith SB; Maixner W; Levitt RC
PLoS Genet; 2019 Jun; 15(6):e1008226. PubMed ID: 31199789
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy.
Orafaie A; Sadeghian H; Bahrami AR; Rafatpanah H; Matin MM
Bioorg Med Chem; 2021 Jan; 30():115951. PubMed ID: 33360579
[TBL] [Abstract][Full Text] [Related]
35. Involvement of neural cell adhesion molecule signaling in glial cell line-derived neurotrophic factor-induced analgesia in a rat model of neuropathic pain.
Sakai A; Asada M; Seno N; Suzuki H
Pain; 2008 Jul; 137(2):378-388. PubMed ID: 17967506
[TBL] [Abstract][Full Text] [Related]
36. Electroacupuncture alleviates neuropathic pain caused by SNL by promoting M2 microglia polarization through PD-L1.
Wu Q; Zheng Y; Yu J; Ying X; Gu X; Tan Q; Tu W; Lou X; Yang G; Li M; Jiang S
Int Immunopharmacol; 2023 Oct; 123():110764. PubMed ID: 37573685
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.
Wang Y; Ma R; Liu F; Lee SA; Zhang L
Front Immunol; 2018; 9():374. PubMed ID: 29556232
[TBL] [Abstract][Full Text] [Related]
38. PD-L1/PD-1 Axis in Glioblastoma Multiforme.
Litak J; Mazurek M; Grochowski C; Kamieniak P; Roliński J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661771
[TBL] [Abstract][Full Text] [Related]
39. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.
Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R
Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890
[TBL] [Abstract][Full Text] [Related]
40. Targeting intrinsically disordered regions facilitates discovery of calcium channels 3.2 inhibitory peptides for adeno-associated virus-mediated peripheral analgesia.
Shin SM; Lauzadis J; Itson-Zoske B; Cai Y; Fan F; Natarajan GK; Kwok WM; Puopolo M; Hogan QH; Yu H
Pain; 2022 Dec; 163(12):2466-2484. PubMed ID: 35420557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
